PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 205 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $148,000 | -78.5% | 17,582 | -77.7% | 0.01% | -47.1% |
| Q4 2019 | $689,000 | +282.8% | 78,688 | +454.1% | 0.02% | +183.3% |
| Q2 2019 | $180,000 | -53.6% | 14,200 | +42.0% | 0.01% | -53.8% |
| Q1 2019 | $388,000 | -53.1% | 10,000 | -75.4% | 0.01% | -59.4% |
| Q4 2018 | $827,000 | +240.3% | 40,654 | +667.1% | 0.03% | +190.9% |
| Q3 2018 | $243,000 | +17.4% | 5,300 | +51.4% | 0.01% | 0.0% |
| Q2 2018 | $207,000 | -89.4% | 3,500 | -78.6% | 0.01% | -93.9% |
| Q3 2017 | $1,960,000 | +580.6% | 16,365 | +395.9% | 0.18% | +496.7% |
| Q2 2017 | $288,000 | -76.9% | 3,300 | -82.3% | 0.03% | -85.8% |
| Q3 2016 | $1,247,000 | – | 18,596 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,400,000 | $25,032,000 | 1.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,365,376 | $14,241,000 | 1.38% |
| Palo Alto Investors LP | 1,343,897 | $14,017,000 | 0.84% |
| Sofinnova Investments, Inc. | 1,197,630 | $12,491,000 | 0.79% |
| Gyon Technologies Capital Management, LP | 29,745 | $310,000 | 0.75% |
| RICE HALL JAMES & ASSOCIATES, LLC | 455,567 | $4,752,000 | 0.20% |
| GLOBEFLEX CAPITAL L P | 63,226 | $659,000 | 0.17% |
| PDT Partners, LLC | 188,538 | $1,966,000 | 0.13% |
| CADENCE CAPITAL MANAGEMENT LLC | 71,179 | $742,000 | 0.11% |
| FRED ALGER MANAGEMENT, LLC | 2,474,029 | $25,804,000 | 0.08% |